Late-Breaking
Late-Breaking Clinical Trials - Structural / LAA [Non-CME]
Kendra Grubb, MD
Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States
Ron Waksman, MD, MSCAI
Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States
Jeroen Bax, MD
Professor in Cardiology
Leiden University Medical Center
Oegstgeest, Zuid-Holland, Netherlands
Megan Coylewright, MD, MPH
Vice Chief of Cardiology and Director of Structural Heart Program
The Erlanger Heart and Lung Institute
Chattanooga, Tennessee, United States
Gregory Fontana, MD
Director, CardioVascular Institute
Hospital Corporation of America
Thousand oaks, United States
Samir Kapadia, MD, FSCAI
Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States
Paul Mahoney, MD, FACC, FSCAI
Chief, Interventional Cardiology, Director, Structural Heart Program
ECU Health
Norfolk, Virginia, United States
Michael Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Toby Rogers, MD, PhD
Associate Professor of Medicine (Cardiology) and Scientific Lead for Structural Heart Disease
Georgetown University and MedStar Washington Hospital Center
Washington, District of Columbia, United States
Horst Sievert, MD, FSCAI, FACC, FESC
Director
CardioVascular Center Frankfurt CVC
Frankfurt, Hessen, Germany
Ibrahim Sultan, MD
Associate Professor of Cardiothoracic Surgery
University of Pittsburgh Medical Center
pittsburgh, Pennsylvania, United States
Speaker: Rishi Puri, MBBS PhD FRACP – Cleveland Clinic
Speaker: David J. Cohen, MD, FSCAI – Cardiovascular Research Foundation
Speaker: Paul D. Mahoney, MD, FACC, FSCAI – ECU Health
Speaker: Atman P. Shah, MD – University of Chicago